
|Articles|June 26, 2007
NIH Announces Pediatric Seizure Study
The National Institute of Child Health and Human Development (NICHD) has announced plans to conduct a large-scale study to determine which of the two most commonly-prescribed medications; diazepam (Valium) or lorazepam (Ativan), is the safer and more effective treatment for children with status epilepticus [more].
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Health system–based clinical pathway improves pediatric lipid screening rates
2
Wesley Kufel, PharmD, discusses doxycycline for post-exposure prevention of Lyme disease in young children
3
FDA approves linaclotide (Linzess) for pediatric patients aged 7 years and older with IBS-C
4
Prenatal COVID-19 exposure linked to adverse neurodevelopment in offspring
5














